Skip to main content Skip to main navigation menu Skip to site footer

Correlation between Left Ventricular Ejection Fraction (LVEF) and six-month mortality risks after hospital discharge following myocardial infarction in patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) at Prof. Dr. R. D. Kandou General Hospita

  • Christian Yosaputra ,
  • Reginald Leopold Lefrandt ,
  • Agnes Lucia Panda ,
  • Janry Pangemanan ,

Abstract

Background: Reduced Left Ventricular Ejection Fraction (LVEF) is considered to worsen prognosis after an acute myocardial infarction (AMI), including Non-ST-elevation myocardial infarction (NSTEMI). This study aims to find a correlation between LVEF with mortality risk after hospital discharge following myocardial infarction using GRACE score among NSTEMI patients.

Methods: Data was collected from the iSTEMI Registry database in Prof. Dr. R. D. Kandou General Hospital from October 3rd 2018, to July 28th 2019. About 122 NSTEMI patients were collected to measure their LVEF by transthoracic echocardiography and routine clinical workup for GRACE score calculation at admission. A descriptive analysis, normality test, and bivariate correlation were applied. A p-value less than 0.05 was considered statistically significant using SPSS version 23 for Windows.

Results: The mean age of the patients was 62.07±11.11 years old and most of the study subjects were male (73%). The mean GRACE score was 118.92±33.52, whereas the mean ejection fraction was 48.76±16.32%. LVEF was negatively significant correlated with the GRACE score (p=0.017; r=-0.230).

Conclusion: Lower LVEF is correlated with increased six-month mortality risk after hospital discharge using GRACE score following myocardial infarction in a patient with Non-ST-elevation myocardial Infarction.

References

  1. Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007;91(4):537-ix.
  2. Prabawa IPY, Lestari AAW, Muliarta IM, Mardhika PE, Pertiwi GAR, Bhargah A, et al. The Stromal Cell-derived Factor-1/ CXCL12 3’A-gene Polymorphism is Related to the Increased Risk of Coronary Artery Disease: A Systematic Review and Meta-analysis. Open Access Maced J Med Sci. 2020;8(F):197-202.
  3. Mitsis A, Gragnano F. Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences. Curr Cardiol Rev. 2021;17(4):e230421189013.
  4. Mele D, Nardozza M, Ferrari R. Left ventricular ejection fraction and heart failure: an indissoluble marriage?. Eur J Heart Fail. 2018;20(3):427-430.
  5. Di Tullio MR, Qian M, Thompson JL, Labovitz AJ, Mann DL, Sacco RL, et al. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. Stroke. 2016;47(8):2031-7.
  6. Tscherny K, Kienbacher C, Fuhrmann V, van Tulder R, Schreiber W, Herkner H, et al. Risk stratification in acute coronary syndrome: Evaluation of the GRACE and CRUSADE scores in the setting of a tertiary care centre. Int J Clin Pract. 2020;74(2):e13444.
  7. Kumar D, Ashok A, Saghir T, Khan N, Solangi BA, Ahmed T, et al. Prognostic value of GRACE score for in-hospital and 6 months outcomes after non-ST elevation acute coronary syndrome. Egypt Heart J. 2021;73(1):22.
  8. Angaran P, Dorian P, Ha ACT, Thavendiranathan P, Tsang W, Leong-Poi H, et al. Association of Left Ventricular Ejection Fraction with Mortality and Hospitalizations. J Am Soc Echocardiogr. 2020;33(7):802-811.e6.
  9. Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, et al. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Circ Heart Fail. 2016;9(3):e002744.
  10. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012;33(14):1750-1757.
  11. Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol. 2012;59(20):1785-95.
  12. Syyli N, Hautamäki M, Antila K, Mahdiani S, Eskola M, Lehtimäki T, et al. Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study. Open Heart. 2019;6(1):e001007.
  13. Toma M, Ezekowitz JA, Bakal JA, O'Connor CM, Hernandez AF, Sardar MR, et al. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial. Eur J Heart Fail. 2014;16(3):334-41.
  14. Perelshtein Brezinov O, Klempfner R, Zekry SB, Goldenberg I, Kuperstein R. Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study. Medicine (Baltimore). 2017;96(9):e6226.
  15. Lam CSP, Gamble GD, Ling LH, Sim D, Leong KTG, Yeo PSD, et al. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J. 2018;39(20):1770-1780.
  16. Hsu JJ, Ziaeian B, Fonarow GC. Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. JACC Heart Fail. 2017;5(11):763-771.
  17. Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J. 2014;168(5):721-30.

How to Cite

Yosaputra, C., Lefrandt, R. L., Panda, A. L., & Pangemanan, J. (2021). Correlation between Left Ventricular Ejection Fraction (LVEF) and six-month mortality risks after hospital discharge following myocardial infarction in patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) at Prof. Dr. R. D. Kandou General Hospita. Bali Medical Journal, 10(3), 975–978. https://doi.org/10.15562/bmj.v10i3.2749

HTML
1

Total
0

Share

Search Panel

Christian Yosaputra
Google Scholar
Pubmed
BMJ Journal


Reginald Leopold Lefrandt
Google Scholar
Pubmed
BMJ Journal


Agnes Lucia Panda
Google Scholar
Pubmed
BMJ Journal


Janry Pangemanan
Google Scholar
Pubmed
BMJ Journal